Home
BioRx, LLC

BioRx, LLC Market Share Analysis for May 2026

diplomat is the nation's largest independent provider of specialty pharmacy and specialty infusion services.

Industry: N/A

Domainbiorx.com

Year Founded2004

Employees51 - 200

Annual Revenue--

BioRx, LLC

BioRx, LLC (including company regionals)

biorx.com

See more website traffic and engagement information

Total visits to BioRx, LLC's top domains

Understand BioRx, LLC market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in BioRx, LLC's top domains

Analyze BioRx, LLC engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on BioRx, LLC's top domains

See how BioRx, LLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

BioRx, LLC top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by BioRx, LLC

These are the website technologies, by industry, used by BioRx, LLC top domains

Social (4)

Instagram

Mobile (3)

Meta Viewport

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

More Technologies

4

See all

News & Signals from BioRx, LLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioRx, LLC launched version of iOS and Android app MyFactor on Jun 18th '18.Specialty pharmacy provider and Diplomat company BioRx on Monday announced the release of the newest version of its iOS and Android app MyFactor.

NewsBioRx, LLC launched physical therapy program on Feb 15th '18.BioRx announced today the launch of a new physical therapy program to help patients, physicians, physical therapists, and health insurers manage the complications and costs of hemophilia-related joint damage.

NewsDiplomatpharmacy acquired BioRx, LLC on Feb 26th '15.BioRx, LLC and Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today a definitive agreement whereby Diplomat will acquire BioRx.